Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases

Molecular Aspects of Medicine

Volumn 18, Issue SUPPL., 1997, Pages 169-179

  Beal, M Flint ^a   Matthews, Russell T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Huntington's disease; Mitochondria; Neuroprotection; Oxidative damage; Parkinson's disease

Indexed keywords

ANTIOXIDANT; GENTISIC ACID; LACTIC ACID; MALONIC ACID; SALICYLIC ACID; UBIDECARENONE; 2 PYROCATECHUIC ACID; 2,5-DIHYDROXYBENZOIC ACID; 2-PYROCATECHUIC ACID; DRUG DERIVATIVE; HYDROXYBENZOIC ACID DERIVATIVE; MALONIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT; SALICYLIC ACID DERIVATIVE; UBIQUINONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG BRAIN LEVEL; DRUG LIVER LEVEL; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; NONHUMAN; OCCIPITAL CORTEX; ORAL DRUG ADMINISTRATION; RAT; RESPIRATORY CHAIN; ANIMAL; ARTICLE; BRAIN; CORPUS STRIATUM; DRUG EFFECT; ELECTRON TRANSPORT; INJECTION; LIVER; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BRAIN; CORPUS STRIATUM; ELECTRON TRANSPORT; GENTISATES; HUMANS; HYDROXYBENZOIC ACIDS; INJECTIONS; LIVER; MALE; MALONATES; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SALICYLIC ACID; SALICYLIC ACIDS; UBIQUINONE;

EID: 0030632815     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0098-2997(97)00024-1     Document Type: Conference Paper

References (35)

1. Abe, K., Fujimura, H., Nishikawa, Y., Yorifuki, S., Mezaki, T., Hirono, N., Nishitani, N. and Kameyama, M. (1991). Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta Neurologica Scandinavica, 83, 356-359.
2. 10 and vitamin E on the peroxidation of human low density lipoprotein subfractions. Proceedings of the National Academy of Sciences of the USA, 92, 9388-9391.
3. Beal, M. F. (1992). Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Annals of Neurology, 31, 119-130.
4. Beal, M. F. (1995). Aging, energy and oxidative stress in neurodegenerative diseases. Annals of Neurology, 38, 357-366.
5. 10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Annals of Neurology, 36, 882-888.
6. Beyer, R. E. (1992). An analysis of the role of coenzyme Q in free radical generation and as an antioxidant. Biochemistry and Cell Biology, 70, 390-403.
7. Beyer, R. E., Segura-Aguilar, J., Di Bernardo, S., Cavazzoni, M., Fato, R., Fiorentini, D., Galli, M. C., Setti, M, Landi, L. and Lenaz, G. (1996). The role of DT-diaphorase in the mainenance of the reduced antioxidant form of coenzyme Q in membrane system. Proceedings of the National Academy of Sciences of the USA, 93, 2528-2532.
8. 10. Neurology, 38, 892-899.
9. 10. Neuroscience Letters, 177, 58-62.
10. 10 pretreatment. Journal of Thoracic and Cardiovascular Surgery, 111, 443-450.
11. De Jong, A. M. P. and Albracht, S. P. J. (1994). Ubisemiquinones as obligatory intermediates in the electron transfer from NADH to ubiquinone. European Journal of Biochemistry, 222, 975-982.
12. Edlund, C., Holmberg, K, Dallner, G., Norrby, E. and Kristensson, K. (1994). Ubiquinone-10 protects neruons from virus-induced degeneration. Journal of Neurochemistry, 63, 634-639.
13. Ernster, L. and Dallner, G. (1995). Biochemical, physiological and medical aspects of ubiquinone function. Biochimica Biophysica Acta, 127, 195-204.
14. Favit, A., Nicoletti, F., Scapagnini, U. and Canonico, P. L. (1992). Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration. Journal of Cerebral Blood Flow Metabolism, 12, 638-645.
15. Floyd, R. A., Watson, J. J. and Wong, P. K. (1984). Sensitive assay of hydroxyl radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. Journal of Biochemical and Biophysical Methods, 10, 221-235.
16. Frei, B., Kim, M. C. and Ames, B. N. (1990). Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proceedings of the National Academy of Sciences of the USA, 87, 4879-4883.
17. Gold, R., Seibel, P., Reinelt, G., Schindler, R., Landwehr, P., Beck, A. and Reichmann, H. (1996). Phosphorus magentic resonance spectroscopy in the evaluation of mitochondrial myopathies: results of a 6-month therapy study with coenzyme Q. European Neurology, 36, 191-196.
18. 10 and idebenone. Journal of Neurological Science, 90, 263-271.
19. Jenkins, B., Koroshetz, W., Beal, M. F. and Rosen, B. (1993). Evidence for an energy metabolism defect in Huntington's disease using localized proton spectroscopy. Neurology, 43, 2689-2695.
20. 10. Annals of Neurology, 41, 160-165.
21. 10 (Y. Yamamura, K. Folkers and Y. Ito, eds), Vol. 2, pp. 3-11. Elsevier/North Holland, Amsterdam.
22. 31P NMR study. Neurology, 39, 399-403.
23. Noack, H., Kube, U. and Augustin, W. (1994). Relations between tocopherol depletion and coenzyme Q during lipid peroxidation in rat liver mitochondria. Free Radical Research, 20, 375-386.
24. 10 on ischemia and reperfusion of the isolated perfused rat heart. Journal of Molecular and Cellular Cardiology, 13, 65-74.
25. 10 in the rat following its oral and intraperitoneal administration. Drug Metabolism and Disposition, 20, 423-427.
26. 10 treatment. Journal of Pharmacology and Experimental Therapeutics, 269, 51-56.
27. Schneider, H., Lemaster, J. J. and Hackembroek, C. R. (1982). Lateral diffusion of ubiquinone during electron transfer in phospholipid- and ubiquinone-enriched mitochondrial membrane. Journal of Biological Chemistry, 257, 10789-10793.
28. 10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Experimental Neurology, 132, 279-283.
29. Schulz, J. B., Henshaw, D. R., Siwek, D., Jenkins, B. G., Ferrante, R. J., Cipolloni, P. B., Kowall, N. W., Rosen, B. R. and Beal, M. F. (1995b). Involvement of free radicals in excitotoxicity in vivo. Journal of Neurochemistry, 64, 2239-2247.
30. Shoffner, J. M., Lott, M. T., Voljavec, A. S., Soueidan, S. A., Costigan, D. A. and Wallace, D. C. (1989). Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proceedings of the National Academy of Sciences of the USA, 86, 7952-7956.
31. Stocker, R., Bowry, V. W. and Frei, B. (1991). Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proceedings of the National Academy of Sciences of the USA, 88, 1646-1650.
32. 10 improves reoxygenation-induced recovery of cardiac contractile force after hypoxia. Journal of Pharmacology and Experimental Therapeutics, 243, 1131-1138.
33. Valls, V., Castelluccio, C., Fato, R., Genova, M. L., Bovina, C., Saez, G., Marchetti, M., Castelli, P. and Lenaz, G. (1994). Protective effect of exogenous coenzyme Q against damage by adriamycin inperfused rat liver. Biochemistry and Molecular Biology International, 33, 633-642.
34. Zhang, Y., Aberg, F., Appelkvist, E.-L., Dallner, G. and Ernster, L. (1995). Uptake of dietary coenzyme Q supplement is limited in rats. Journal of Nutrition, 125, 446-453.
35. Zierz, S., von Wersebe, O., Bleistein, J. and Jerusalem, F. (1990). Exogenous coenzyme Q (CoQ) fails to increase CoQ in skeletal muscle of two patients with mitochondrial myopathies. Journal of Neurological Science, 95, 283-290.